Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.23
-1.27 (-4.98%)
At close: Apr 28, 2026, 4:00 PM EDT
24.49
+0.26 (1.07%)
After-hours: Apr 28, 2026, 6:42 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.46 billion as of April 28, 2026. Its market cap has increased by 49,672.74% in one year.
Market Cap
1.46B
Enterprise Value
1.20B
1-Year Change
49,672.74%
Ranking
Category
Stock Price
$24.23
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.46B, an increase of 296.21%. That is a compound annual growth rate of 28.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.57B |
| Immatics | 1.54B |
| Ardelyx | 1.50B |
| Bicara Therapeutics | 1.49B |
| Agios Pharmaceuticals | 1.48B |
| Immunocore Holdings | 1.48B |
| Biohaven | 1.48B |
| Iovance Biotherapeutics | 1.46B |